Sciarra Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCIARRA LABS
SCIARRA LABS has two approved drugs.
Summary for Sciarra Labs
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Sciarra Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sciarra Labs | TALC | talc | POWDER;INTRAPLEURAL | 021388-001 | Dec 15, 2003 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sciarra Labs | SCLEROSOL | talc | AEROSOL;INTRAPLEURAL | 020587-001 | Dec 24, 1997 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
